(Q44563647)

4 December 2017

Mapping the kinase domain of Janus Kinase 3. (English)

1 reference

4 December 2017

Christopher Adams

1

1 reference

4 December 2017

David J Aldous

2

1 reference

4 December 2017

Shelley Amendola

3

1 reference

4 December 2017

Paul Bamborough

4

1 reference

4 December 2017

Colin Bright

5

1 reference

4 December 2017

Sarah Crowe

6

1 reference

4 December 2017

Paul Eastwood

7

1 reference

4 December 2017

Garry Fenton

8

1 reference

4 December 2017

Martyn Foster

9

1 reference

4 December 2017

Trevor K P Harrison

10

1 reference

4 December 2017

Sue King

11

1 reference

4 December 2017

Justine Lai

12

1 reference

4 December 2017

Christopher Lawrence

13

1 reference

4 December 2017

Jean-Philippe Letallec

14

1 reference

4 December 2017

Clive McCarthy

15

1 reference

4 December 2017

Neil Moorcroft

16

1 reference

4 December 2017

Kenneth Page

17

1 reference

4 December 2017

Sudha Rao

18

1 reference

4 December 2017

Jane Redford

19

1 reference

4 December 2017

Shazia Sadiq

20

1 reference

4 December 2017

Keith Smith

21

1 reference

4 December 2017

John E Souness

22

1 reference

4 December 2017

Sukanthini Thurairatnam

23

1 reference

4 December 2017

Mark Vine

24

1 reference

4 December 2017

Barry Wyman

25

1 reference

4 December 2017

language of work or name

English

0 references

publication date

1 September 2003

1 reference

Bioorganic & Medicinal Chemistry Letters

4 December 2017

1 reference

4 December 2017

13

1 reference

4 December 2017

3105-3110

1 reference

4 December 2017

18

1 reference

Protein kinases as therapeutic targets

4 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900657-7

7 January 2021

Protein tyrosine kinase inhibitors: new treatment modalities?

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900657-7

7 January 2021

Interaction of IL-2R beta and gamma c chains with Jak1 and Jak3: implications for XSCID and XCID

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900657-7

7 January 2021

Interleukin-2 receptor gamma chain mutation results in X-linked severe combined immunodeficiency in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900657-7

7 January 2021

The molecular basis of X-linked severe combined immunodeficiency: defective cytokine receptor signaling

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900657-7

7 January 2021

Jaks and STATs: biological implications

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900657-7

7 January 2021

The interleukin-2 receptor gamma chain: its role in the multiple cytokine receptor complexes and T cell development in XSCID

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900657-7

7 January 2021

Targeting JAK3 with JANEX-1 for prevention of autoimmune type 1 diabetes in NOD mice

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900657-7

7 January 2021

Crystal structures of the myristylated catalytic subunit of cAMP-dependent protein kinase reveal open and closed conformations

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900657-7

7 January 2021

Crystal structure of the activated insulin receptor tyrosine kinase in complex with peptide substrate and ATP analog

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900657-7

7 January 2021

Structures of the tyrosine kinase domain of fibroblast growth factor receptor in complex with inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900657-7

7 January 2021

Synthesis and biological evaluations of 3-substituted indolin-2-ones: a novel class of tyrosine kinase inhibitors that exhibit selectivity toward particular receptor tyrosine kinases

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900657-7

7 January 2021

Protein kinase inhibition by staurosporine revealed in details of the molecular interaction with CDK2

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900657-7

7 January 2021

Staurosporine-induced conformational changes of cAMP-dependent protein kinase catalytic subunit explain inhibitory potential

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900657-7

7 January 2021

A highly specific inhibitor of human p38 MAP kinase binds in the ATP pocket

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900657-7

7 January 2021

Active and inactive protein kinases: structural basis for regulation

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900657-7

7 January 2021

Functional activation of Jak1 and Jak3 by selective association with IL-2 receptor subunits

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900657-7

7 January 2021

Phosphorylation and activation of the Jak-3 Janus kinase in response to interleukin-2.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900657-7

7 January 2021

10.1016/S0960-894X(03)00657-7

Identifiers

DOI

1 reference

4 December 2017

1 reference